Literature DB >> 8477699

Oxygenation of lipoproteins by mammalian lipoxygenases.

J Belkner1, R Wiesner, J Rathman, J Barnett, E Sigal, H Kühn.   

Abstract

Oxidative modification converts low-density lipoprotein (LDL) into its atherogenic form and appears to be a necessary precondition for LDL uptake by macrophages during foam cell formation. Cellular lipoxygenases have been implicated in this process. We studied the interaction of purified mammalian lipoxygenases with human LDL in vitro and found that the arachidonate 15-lipoxygenases of rabbit and man are capable of oxygenating lipoproteins as indicated by oxygen uptake and by the formation of thiobarbituric-acid-reactive substances. Furthermore, oxygenated polyenoic fatty acids, such as 13-hydro(pero)xy-9Z,11E-octadecadienoic acid and 15-hydro(pero)xy-5,8,11,13(Z,Z,Z,E)-eicosatetraenoic acid were detected in the lipid compartment of various lipoproteins classes after lipoxygenase treatment. More than 90% of the oxygenated polyenoic fatty acids were found in the ester-lipid fraction, particularly in the cholesterol esters, whereas only small amounts of free hydro(pero)xy polyenoic fatty acids were detected. Lipoxygenase-catalyzed oxygenation of LDL is not restricted to the lipid compartment but also leads to a cooxidative modification of the apoproteins as indicated by changes in the electrophoretic mobility and by the formation of carbonyl derivatives of amino acid side chains. The possible biological significance of lipoxygenase-induced oxidative modification of lipoproteins in the pathogenesis of atherosclerosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477699     DOI: 10.1111/j.1432-1033.1993.tb17755.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  29 in total

1.  The mechanism of oxidation-induced low-density lipoprotein aggregation: an analogy to colloidal aggregation and beyond?

Authors:  S Xu; B Lin
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  Cholesteryl ester acyl oxidation and remodeling in murine macrophages: formation of oxidized phosphatidylcholine.

Authors:  Patrick M Hutchins; Robert C Murphy
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

3.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 4.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

5.  Modifications of proteins by polyunsaturated fatty acid peroxidation products.

Authors:  H H Refsgaard; L Tsai; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 6.  Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL.

Authors:  Patrick M Hutchins; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

7.  Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Authors:  Nicola Santoro; Sonia Caprio; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2013-08-01

Review 8.  Bioactive lipids and pathological retinal angiogenesis.

Authors:  Khaled Elmasry; Ahmed S Ibrahim; Samer Abdulmoneim; Mohamed Al-Shabrawey
Journal:  Br J Pharmacol       Date:  2018-11-19       Impact factor: 8.739

9.  Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.

Authors:  V A Folcik; R A Nivar-Aristy; L P Krajewski; M K Cathcart
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Omega-oxidation impairs oxidizability of polyenoic fatty acids by 15-lipoxygenases: consequences for substrate orientation at the active site.

Authors:  I Ivanov; K Schwarz; H G Holzhütter; G Myagkova; H Kühn
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.